Back to TMO
Assenagon Asset Management S.A. → TMO
Assenagon Asset Management S.A. TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
9
Latest value
$144.6M
Q3 2026
Peak value
$298.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $298.4M |
| Q3 2025 | $6.8M |
| Q4 2025 | $6.2M |
| Q4 2025 | $9.5M |
| Q1 2026 | $91.6M |
| Q1 2026 | $17.4M |
| Q2 2026 | $171.4M |
| Q2 2026 | $171.4M |
| Q3 2026 | $144.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $144.6M | 214.2K | — | — |
| Q2 2026 | $171.4M | 341.8K | — | — |
| Q2 2026 | $171.4M | 341.8K | — | — |
| Q1 2026 | $17.4M | 345.7K | — | — |
| Q1 2026 | $91.6M | 186.4K | — | — |
| Q4 2025 | $9.5M | 255.7K | — | — |
| Q4 2025 | $6.2M | 10.7K | — | — |
| Q3 2025 | $6.8M | 255.7K | — | — |
| Q3 2025 | $298.4M | 615.3K | — | — |
Other funds holding TMO
$17.6B
$15.8B
$14.7B
$10.1B
$9.6B
$9.6B